Home/Filings/4/0001209191-11-061815
4//SEC Filing

APLIN JOHN C 4

Accession 0001209191-11-061815

CIK 0001235007other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 5:08 PM ET

Size

5.4 KB

Accession

0001209191-11-061815

Insider Transaction Report

Form 4
Period: 2011-12-16
APLIN JOHN C
Director
Transactions
  • Purchase

    Common Stock

    2011-12-16$3.27/sh+20,000$65,40021,063 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.22 to $3.37, inclusive. The reporting person undertakes to provide Endoycte, Inc., any security holder of Endocyte, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]This amount includes 693 shares of common stock distributed to Mr. Aplin from CID Equity Capital VIII, L.P. and 370 shares of common stock distributed to Mr. Aplin from CID Seed Fund, L.P. Mr. Aplin previously reported indirect ownership of the shares owned by these entities.

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeother
IncorporatedIN

Related Parties

1
  • filerCIK 0001033188

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:08 PM ET
Size
5.4 KB